Studies have found that sST2 in combination with BNP/NT-proBNP can better predict the occurrence of HF adverse events, and sst2 is not affected by renal function, so it has potential value for the prognosis of CRS (Yancy et al., 2017; Chirinos et al., 2020). This evidence concerns the gene NPPB and congenital rubella syndrome.